LIVE
OMCL
Omnicell, Inc. · Health Care - Pharmacy Automation
$39.05
-10.89% this month
VERSUS
⟷
COMPARE
NXST
Nexstar Media Group, Inc. · Communication Services - Broadcasting
$164.16
-12.97% this month
Scoreboard verdict
Across AI score, momentum, valuation, upside, operating margin
OMCL
2
NXST
2
Comparison scoreboard
MIXED SETUPAI Score
OMCL 34.6
NXST ✓46.9
1Y Return
OMCL ✓+38.13%
NXST +2.14%
Fwd P/E
OMCL 17.79
NXST ✓6.78
Target Up.
OMCL ✓+56.94%
NXST +53.28%
Op. Margin
OMCL N/A
NXST N/A
Metrics last refreshed: 6/20/2026
Quick take
OMCL vs NXST Stock Comparison: AI Score, Valuation, Performance and Upside
OMCL (Omnicell) and NXST (Nexstar) are very different businesses — Omnicell providing hospital pharmacy automation with a software transition underway, and Nexstar operating the largest U.S. local television broadcasting group navigating cord-cutting headwinds. These companies rarely appear in direct comparison except in diversified mid-cap screens.
OMCL vs NXST contrasts a healthcare technology automation company undergoing a software business model transition against a traditional local broadcasting company navigating secular cord-cutting pressures.
Live analysis · updated 6/20/2026
OMCL and NXST are closely matched — they split the tracked metrics evenly. OMCL has delivered stronger 1-year price return (+38.13% vs +2.14%), though NXST trades at the lower forward P/E (6.78x vs 17.79x). Analyst consensus implies meaningfully more upside for OMCL (+56.94%) than for NXST (+53.28%).
Normalized 1Y performance
OMCL
NXST
Recent returns
OMCL
NXST
Analyst price targets & sentiment
OMCL · 7 analysts
STRONG BUYHOLDSTRONG SELL
Strong Buy (1.4/5.0)
Price target range
analyst low$55.00
analyst high$70.00
analyst mean$61.29
current price$39.05
+56.9% upside to analyst mean
NXST · 8 analysts
STRONG BUYHOLDSTRONG SELL
Strong Buy (1.3/5.0)
Price target range
analyst low$205.00
analyst high$290.00
analyst mean$251.63
current price$164.16
+53.3% upside to analyst mean
Who should consider this stock?
OMCL may suit investors who:
- →Want hospital pharmacy automation exposure with a recurring software and services transformation underway
- →Value Omnicell's dominant dispensing cabinet installed base as a platform for Advanced Services outsourcing revenue
- →See healthcare automation as a growing priority as hospitals seek to reduce medication errors and pharmacy costs
NXST may suit investors who:
- →Want local TV broadcasting exposure at a discounted valuation reflecting cord-cutting headwinds
- →Value political advertising revenue cyclicality as a predictable above-average earnings boost in election years
- →See Nexstar's scale and retransmission contract negotiation leverage as providing revenue stability despite secular challenges
Performance & AI score
| Metric | OMCL | NXST |
|---|---|---|
| AI score | 34.6 | 46.9 |
| AI rank | #1694 | #640 |
| Latest close | $39.05 | $164.16 |
| 1M return | -10.89% | -12.97% |
| 6M return | -14.72% | -18.81% |
| 1Y return | +38.13% | +2.14% |
$10,000 invested — hypothetical growth (dividends reinvested)
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | OMCL | NXST |
|---|---|---|
| 1Y ago | $13.81K (+38.1%) started 2025-06-18 | $10.6K (+6.0%) started 2025-06-18 |
| 5Y ago | $2.72K (-72.8%) started 2021-06-18 | $16.14K (+61.4%) started 2021-06-18 |
| 10Y ago | $11.72K (+17.2%) started 2016-06-20 | $58.59K (+485.9%) started 2016-06-20 |
Hypothetical — past performance does not guarantee future results.
Valuation & upside potential
| Metric | OMCL | NXST |
|---|---|---|
| Market cap | $1.78B | $5.01B |
| Trailing P/E | 88.75 | 34.78 |
| Forward P/E | 17.79 | 6.78 |
| Price/Sales | 1.45 | 0.98 |
| EV/Revenue | 1.45 | 3.40 |
| Analyst target | $61.29 | $251.63 |
| Target upside | +56.94% | +53.28% |
Growth, profitability & risk
| Metric | OMCL | NXST |
|---|---|---|
| Revenue growth | 14.90% | 13.10% |
| Earnings growth | N/A | 51.00% |
| EPS growth | N/A | +51.00% |
| FCF margin | +9.19% | +12.99% |
| Operating margin | N/A | N/A |
| Profit margin | 1.67% | 3.23% |
| ROIC proxy | 1.63% | 6.61% |
| Return on equity | 1.63% | 6.61% |
| Dividend yield | 0.00% | 4.32% |
| Beta | 0.96 | 0.90 |
| Debt/equity | 16.09 | 576.20 |
| Current ratio | 1.50 | 1.76 |
| Quick ratio | 1.04 | 1.57 |
Drawdown & downside risk
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
1Y risk snapshot
OMCL max drawdown37.05%
NXST max drawdown34.66%
OMCL max wkly drop25.05%
NXST max wkly drop19.57%
5Y risk snapshot
OMCL max drawdown86.59%
NXST max drawdown35.73%
OMCL max wkly drop36.66%
NXST max wkly drop19.57%
10Y risk snapshot
OMCL max drawdown86.59%
NXST max drawdown64.56%
OMCL max wkly drop36.66%
NXST max wkly drop34.83%
Performance metrics by period
| Period | Metric | OMCL | NXST |
|---|---|---|---|
| 1Y | Growth | +38.13% | +2.14% |
| CAGR | +38.16% | +2.14% | |
| Sharpe ratio | 0.82 | 0.10 | |
| Max drawdown | 37.05% | 34.66% | |
| Max daily drop | 16.30% | 13.11% | |
| Max wkly drop | 25.05% | 19.57% | |
| 5Y | Growth | -72.82% | +35.43% |
| CAGR | -22.94% | +6.25% | |
| Sharpe ratio | -0.36 | 0.22 | |
| Max drawdown | 86.59% | 35.73% | |
| Max daily drop | 34.52% | 13.11% | |
| Max wkly drop | 36.66% | 19.57% | |
| 10Y | Growth | +17.20% | +333.25% |
| CAGR | +1.60% | +15.80% | |
| Sharpe ratio | 0.15 | 0.46 | |
| Max drawdown | 86.59% | 64.56% | |
| Max daily drop | 34.52% | 19.09% | |
| Max wkly drop | 36.66% | 34.83% |
Business comparison
| Category | OMCL | NXST |
|---|---|---|
| Company | Omnicell, Inc. | Nexstar Media Group, Inc. |
| Sector | Health Care - Pharmacy Automation | Communication Services - Broadcasting |
| Industry | N/A | N/A |
| Core business | Omnicell provides pharmacy automation and medication management solutions to hospitals and health systems, including automated dispensing cabinets, central pharmacy automation, IV compounding robots, and a cloud-based pharmacy intelligence platform. | Nexstar is the largest local television broadcasting company in the United States by station count, operating and providing services to over 200 full power television stations and various digital media assets in markets across the country. |
| Investor focus | Investors track Omnicell's recurring connected devices and software revenue, Advanced Services (pharmacy-as-a-service) adoption, and the company's transition from hardware-focused to software and services-led revenue. | Investors track Nexstar's retransmission consent revenue from cable and satellite providers, political advertising revenue in election years, and the company's ability to manage declining core advertising with growing digital and retransmission revenues. |
OMCL strengths
- →Dominant position in hospital automated dispensing cabinets creates sticky recurring revenue from service and software contracts
- →Advanced Services pharmacy outsourcing model provides health systems with predictable pharmacy operations costs
- →Medication management automation addresses critical hospital priorities around medication error reduction and pharmacy efficiency
NXST strengths
- →Largest U.S. local TV broadcaster by station count provides significant scale for retransmission consent negotiation leverage
- →Political advertising creates significant revenue bump in election years, providing above-average earnings in even-numbered years
- →CW Network acquisition provides national broadcast network content and distribution reach
Risks to watch — OMCL
- →Hospital capital budget pressures can delay automation purchases, making hardware revenues lumpy
- →Transition from hardware-centric to software/services model takes time and creates near-term revenue headwinds
- →Competition from BD (Becton Dickinson) Pyxis systems in the core automated dispensing cabinet market
Risks to watch — NXST
- →Cord-cutting reduces cable and satellite subscribers who pay retransmission fees, the primary revenue growth driver
- →Local TV advertising is in secular decline as digital advertising captures marketing budgets
- →High debt from acquisition-driven growth constrains financial flexibility and amplifies cyclical earnings volatility
Frequently asked questions
Free public comparison
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
More comparisons
Browse all 1,000 comparisons →